raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:90301

Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome

Type
Disease
Group
Disorder
Age of onset
Adult
Status
active

This syndrome is characterised by the association of acanthosis nigricans, insulin resistance, severe muscle cramps and acral hypertrophy.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome
frSyndrome d'acanthosis nigricans-résistance à l'insuline-crampes-hypertrophie acrale
deAcanthosis nigricans-Insulinresistenz-Muskelkrämpfe Akrenvergrößerung-Syndrom
esSíndrome de acantosis nigricans-resistencia a la insulina-calambres musculares-agrandamiento acral
itSindrome acanthosis nigricans-resistenza all'insulina-crampi muscolari-ingrandimento delle estremità
nlAcanthosis nigricans - insulineresistentie - spierkrampen - acrale vergroting-syndroom
ptSíndrome de acantose nigricans-resistência à insulina-cãibras musculares-alargamento acral
plRogowacenie ciemne - oporność na insulinę - mrowienie mięśni - powiększenie kończyn
csSyndrom zahrnující acanthosis nigricans, inzulinovou rezistenci, svalové křeče a akrální zvětšení
ukСиндром чорного акантозу-інсулінорезистентності-мязових судом-збільшення акрального отвору
zh黑棘皮病-胰岛素抵抗-肌肉痉挛-肢端肿大综合征
trAkantosis nigrikans-insülin direnci-kas krampları-akral genişleme sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM200170Evalidated
ICD-10E34.8NTBTattributednot yet validated
ICD-115A44NTBTattributedvalidated
MONDO0008696Evalidated
UMLSC4305258Evalidated
GARD453Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families5 casesWorldwideCase(s)Validated6997748[PMID]_6587221[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

9 annotations · validated 2015-11-04
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0000956Acanthosis nigricans
HP:0000845Elevated circulating growth hormone concentration
HP:0008675Enlarged polycystic ovaries
HP:0001007Hirsutism
HP:0000855Insulin resistance
HP:0000831Insulin-resistant diabetes mellitus
HP:0003394Muscle spasm
HP:0000147Polycystic ovaries
Frequent (79-30%)
HP:0000105Enlarged kidney

Run the differential on the 8 obligate / very frequent terms

Annotation source: 6997748[PMID]

7

Sources for this card